# Anteris Technologies Global Corp. (AVR)

> Source: Nexqual · https://nexqual.com/AVR · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Anteris Technologies Global Corp. (AVR), nexqual.com/AVR" · informational, not investment advice.

**Price:** USD 6.36 (+1.60% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 6.26 · day 6.12–6.38 · 52w 3.3–11.06 · market cap $620M · NGM

## Key facts
- Analysts: Buy (mean 2.20 on a 1–5 scale) (5 analysts), mean target USD 14 (range 10–16).
- Total return with dividends: 1Y +28.2% vs S&P 500 +18.1%; 5Y +13.6% vs S&P 500 +85.1%.
- Next earnings: 2026-11-12, EPS estimate USD -0.31, revenue estimate $3.9M.

## Analysts
Consensus Buy (mean 2.20 on a 1–5 scale), 5 analysts; mean target USD 14 (low 10, high 16).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-14 | Cantor Fitzgerald | Reiterated | Overweight | $15 |
| 2026-10-07 | Barclays | Initiated | Equal-Weight | $10 |
| 2026-08-14 | Cantor Fitzgerald | Reiterated | Overweight | $15 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2024-12-09) |
|---|---|---|
| Total return | +28.2% | +13.6% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | +28.3% | +7.1% |
| Volatility (annualized) | 66.7% | 89.9% |
| Max drawdown | -46.8% (Oct 2025→Nov 2025) | -70.1% (Feb 2025→Apr 2025) |

## Peers (Medical Devices)
ESTA (Establishment Labs Holdings Inc) USD 61.36 +4.98% · ALMR (Alamar Biosciences, Inc.) USD 27.42 +16.58% · INSP (Inspire Medical Systems, Inc.) USD 70.12 +1.83% · BFLY (Butterfly Network, Inc.) USD 7.85 -3.09% · AXGN (AxoGen, Inc.) USD 35.63 -1.49% · UFPT (UFP Technologies, Inc.) USD 297.19 +0.99%

## More
Full page: https://nexqual.com/AVR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt